Skip to main content
. 2014 Jun 25;2014:396064. doi: 10.1155/2014/396064

(c).

Stage 1 Stage 2 Stage 3 Stage 4 P-value
sIL-2R (pg/mL ± SD) 687.9 ± 497.4 725.1 ± 740.6 725.3 ± 460.9 2021.9 ± 1922.4 P < 0.001
sB7-H3 (ng/mL ± SD) 14.7 ± 12.4 10.2 ± 2.5 12.2 ± 6.9 17.4 ± 9.3 P = 0.044
sCTLA-4 (ng/mL ± SD) 2.2 ± 0.7 1.9 ± 0.3 2.5 ± 1.1 2.3 ± 0.6 P = 0.179

CCRCC: clear cell renal cell carcinoma, sIL-2R: soluble interleukin-2 receptor, sB7-H3: soluble B7-H3, and sCTLA-4: soluble cytotoxic T lymphocyte associated antigen-4.